Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: An International Task Force Consensus Statement.
第一作者:
Domenico,Corrado
第一单位:
From the Department of Cardiac, Thoracic and Vascular Sciences, University of Padova Medical School, Padova, Italy (D.C., B.B., C.Basso, G.T.); Heart Center Osnabrück-Bad Rothenfelde, Marienhospital Osnabrück, Osnabrück, Germany (T.W.); New England Cardiac Arrhythmia Center, Tufts University School of Medicine, Boston, MA (M.S.L., N.A.M.E.); ICIN-Netherlands Heart Institute, Utrecht, The Netherlands (R.N.W.H.); University of Pennsylvania Health System, Philadelphia, PA (F.M.); First Cardiology Department, University of Athens, Medical School, Athens, Greece (A.A.); Cardiovascular Center, University Hospital Zurich, Zurich, Switzerland (C. Brunckhorst, C.S., F.D.); Yannis Protonotarios Medical Centre, Hora Naxos, Greece (A.T., N.P.); Johns Hopkins Hospital, Baltimore, MD (H.T., H.C.); University Hospital of Münster, Münster, Germany (M.P.); Center of Sports Sciences, Rome, Italy (A.P.); The Heart Hospital, London, UK (W.J.M.); and University of Arizona, Tucson (F.I.M.). domenico.corrado@unipd.it.
作者:
主题词
肾上腺素能β受体拮抗剂(Adrenergic beta-Antagonists);顾问委员会(Advisory Committees);算法(Algorithms);抗心律失常药(Anti-Arrhythmia Agents);心律失常性右心室发育不良(Arrhythmogenic Right Ventricular Dysplasia);导管消融术(Catheter Ablation);除颤器, 植入型(Defibrillators, Implantable);心电描记术(Electrocardiography);心脏移植(Heart Transplantation);人类(Humans);国际机构(International Agencies);危险因素(Risk Factors)
DOI
10.1161/CIRCULATIONAHA.115.017944
PMID
26216213
发布时间
2022-03-16
- 浏览31

Circulation
441-53页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文